LobbyingHealth Equity Coalition for Chronic Disease lobbying by quarter
Health Equity Coalition for Chronic Disease's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.
Health Equity Coalition for Chronic Disease
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $80K | 1 |
| Q2 2024 | $80K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$650K · 12 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES10 reports
- SENATE10 reports
- White House Office7 reports
- Health & Human Services, Dept of (HHS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| NVG | $650K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JULIO C. LAINEZ | Legislative Director, Rep. Seth Moulton; Legislative Aide, Senate Majority Leader Harry Reid; Systems Administrator, Senate Majority Leader Harry Reid | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | NVG | Under $5,000 |
| 04/20for Q1 | NVG | Under $5,000 |
| 01/20for Q4 2025 | NVG | Under $5,000 |
| 25/10/21for Q3 2025 | NVG | Under $5,000 |
| 25/07/20for Q2 2025 | NVG | $80K |
| 25/04/19for Q1 2025 | NVG | $80K |
| 25/01/20for Q4 2024 | NVG | $30K |
| 24/10/21for Q3 2024 | NVG | $80K |
| 24/07/22for Q2 2024 | NVG | $80K |
| 24/04/22for Q1 2024 | NVG | $80K |
| 24/01/22for Q4 2023 | NVG | $60K |
| 23/10/19for Q3 2023 | NVG | $60K |
| 23/07/20for Q2 2023 | NVG | $60K |
| 23/04/20for Q1 2023 | NVG | $20K |
| 23/01/20for Q4 2022 | NVG | $20K |